Atrial Septal Defect.
Bradley EA, Zaidi AN.
Cardiol Clin. 2020 Aug;38(3):317-324. doi: 10.1016/j.ccl.2020.04.001. Epub 2020 Jun 6.
Atrial septal defect closure with left ventricular dysfunction.
Tadros VX, Asgar AW.
EuroIntervention. 2016 May 17;12 Suppl X:X13-X17. doi: 10.4244/EIJV12SXA3.
Patent Foramen Ovale and Atrial Septal Defect.
Aoun J, Hatab T, Volpi J, Lin CH.
Cardiol Clin. 2024 Aug;42(3):417-431. doi: 10.1016/j.ccl.2024.02.019. Epub 2024 Mar 28.
Secundum atrial septal defect.
Chia RC, Salazar P, Al-Yafi M, Romano S, Farzaneh-Far A.
QJM. 2018 Aug 1;111(8):571-572. doi: 10.1093/qjmed/hcy030.
Echocardiographic evaluation of patent foramen ovale and atrial septal defect.
Hari P, Pai RG, Varadarajan P.
Echocardiography. 2015 Jan;32 Suppl 2:S110-24. doi: 10.1111/echo.12625. Epub 2014 May 29.
Strategies for Managing Functional Tricuspid Regurgitation in Adults With a Secundum Atrial Septal Defect.
Webb GD, Opotowsky AR.
JACC Cardiovasc Interv. 2017 Nov 13;10(21):2219-2221. doi: 10.1016/j.jcin.2017.07.014. Epub 2017 Oct 18.
Secundum Atrial Septal Defects Transcatheter Closure: An Updated Reappraisal.
Rigatelli G, Gianese F, Zuin M.
Cardiovasc Revasc Med. 2022 Nov;44:92-97. doi: 10.1016/j.carrev.2022.06.002. Epub 2022 Jun 6.
Percutaneous secundum atrial septal defect closure for the treatment of atrial arrhythmia in the adult: A meta-analysis.
O'Neill L, Floyd CN, Sim I, Whitaker J, Mukherjee R, O'Hare D, Gatzoulis M, Frigiola A, O'Neill MD, Williams SE.
Int J Cardiol. 2020 Dec 15;321:104-112. doi: 10.1016/j.ijcard.2020.07.014. Epub 2020 Jul 15.
Molecular Pathways and Animal Models of Atrial Septal Defect.
Magnan RA, Kang L, Degenhardt KR, Anderson RH, Jay PY.
Adv Exp Med Biol. 2024;1441:481-493. doi: 10.1007/978-3-031-44087-8_25.
Practical Therapeutic Management of Percutaneous Atrial Septal Defect Closure.
Tanaka S, Imamura T, Narang N, Fukuda N, Ueno H, Kinugawa K.
Intern Med. 2022 Jan 1;61(1):15-22. doi: 10.2169/internalmedicine.5944-20. Epub 2021 Feb 15.
